Skip to main content
  • 22 Accesses

Abstract

The prevalence of HSV-1 infections is high in all areas of the world. With a slight decline from the 1950s where more than 90% of the general population over 30 years of age had serological evidence of infection with HSV-1, the has been a slight decline to around 60%–80% in recent decades in Western countries. This decline has been attributed to improved hygiene.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 74.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Raborn GW, McGaw WT, Grace M et al (1989) Herpes labialis treatment with acyclovir 5% modified aqueous cream: a double-blind randomized trial. Oral Surg Oral Med Oral Pathol 67: 676–679

    Article  PubMed  CAS  Google Scholar 

  2. Van Vloten WA, Swart RNJ, Pot FJ (1983) Topical acyclovir therapy in patients with recurrent oro-facial herpes simplex infections. J Antimicrob Chemother 12 [Suppl B]: 89–93

    Article  PubMed  Google Scholar 

  3. Shaw M, King M, Best JM (1985) Failure of acyclovir cream in treatment of recurrent herpes labialis. BMJ 291: 7–9

    Article  PubMed  CAS  Google Scholar 

  4. Fiddian AP, Yeo JM, Stubbings R et al (1983) Successful treatment of herpes labialis with topical acyclovir. BMJ 286: 1699–1701

    Article  PubMed  CAS  Google Scholar 

  5. Spruance SL, Rea TL, Thoming C et al (1997) Penciclovir cream for the treatment of herpes simplex labialis. A randomized, multicenter, double-blind, placebo-controlled trial. JAMA 227: 1374–1379

    Google Scholar 

  6. Spruance SL, Stewart JCB, Freeman DJ et al (1990) Early application of topical 15% idoxuridine in dimethyl sulfoxide shortens the course of herpes simplex labialis: a multicenter placebo-controlled trial. J Infect Dis 161: 191–197

    Article  PubMed  CAS  Google Scholar 

  7. Spruance SL, Stewart JCB, Rowe NH et a1 (1990) Treatment of recurrent herpes simplex labialis with oral acyclovir. J Infect Dis 161: 185–190

    Article  PubMed  CAS  Google Scholar 

  8. Spruance SL (1993) Prophylactic chemotherapy with acyclovir for recurrent herpes simplex labialis (review). J Med Virol 41 [Suppl 11: 27–32

    Article  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2000 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Kroon, S. (2000). Herpes Simplex Virus Infection (Oro-Facial). In: Katsambas, A.D., Lotti, T.M. (eds) European Handbook of Dermatological Treatments. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-03835-2_42

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-03835-2_42

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-03837-6

  • Online ISBN: 978-3-662-03835-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics